Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bush Generic Rx Proposal Has PhRMA Backing As Alternative To Legislation

Executive Summary

The Pharmaceutical Research & Manufacturers of America is expected to endorse the Bush Administration's proposed generic drug reforms as an alternative to a Congressional reopening of Waxman/Hatch

You may also be interested in...



DTC Ads Remain Controversial Despite Positive Study Results, PhRMA Says

The Pharmaceutical Research & Manufacturers of America is prepared to use the results of recent direct-to-consumer advertising studies to respond to critics of the marketing practice

DTC Ads Remain Controversial Despite Positive Study Results, PhRMA Says

The Pharmaceutical Research & Manufacturers of America is prepared to use the results of recent direct-to-consumer advertising studies to respond to critics of the marketing practice

PhRMA Wants Amended ANDAs To Trigger 30-Month Stays

FDA should specify that ANDAs which change certification from Paragraph III to Paragraph IV should trigger for a 30-month stay, the Pharmaceutical Research & Manufacturers of America states in comments on FDA's proposed rule

Related Content

Latest News
See All
UsernamePublicRestriction

Register

PS040893

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel